Moderna
MRNA
#894
Rank
A$40.13 B
Marketcap
A$101.14
Share price
3.61%
Change (1 day)
139.50%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: A$40.13 Billion

As of June 2026 Moderna has a market cap of A$40.13 Billion. This makes Moderna the world's 894th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026A$40.13 B120.49%
2025A$18.20 B-26.69%
2024A$24.82 B-55.39%
2023A$55.65 B-45.11%
2022A$101.40 B-28.61%
2021A$142.03 B164.2%
2020A$53.76 B471.83%
2019A$9.40 B31.92%
2018A$7.12 B

End of Day market cap according to different sources

On Jun 28th, 2026 the market cap of Moderna was reported to be:

A$38.73 Billion
by Nasdaq info icon info icon
A$38.73 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$903.00 B 2,150.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$436.34 B 987.27%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
A$463.69 B 1,055.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
A$0.81 B-97.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
A$4.32 B-89.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
A$1.2 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$56.86 B 41.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
A$16.45 B-59.00%๐Ÿ‡บ๐Ÿ‡ธ USA